glp-1 ileus class action in michigan The FDA sent a warning letter to the maker of Ozempic and Wegovy over unreported potential side effects. Here's what to know Glucagon-like peptide-1 receptor: mechanisms and

Compared with other second- or third-line glucose-lowering medications, the GLP-1RAs demonstrated a lower rate of adverse CVEs, including heart failure (HR 0.88

From Lizzie's insulin resistance to Jackie's journey towards a holistic understanding of metabolic health, we uncover the challenges and triumphs of their experience.

An editorial review of Agile Health business model, compounded-pharmacy pathway, patient reports, and fair-balance safety

Petrelintide, a long-acting amylin analog, is being tested in Phase II trials and may offer improved tolerability and sustained weight loss.

Recovery Centers of Americas Chief Medical Officer Jason Kirby, DO, MBA, DFASAM, recently authored an article featured in Drug Discovery Online.

GLP-2 (Tirzepatide) is a dual incretin receptor agonist widely utilized in preclinical research involving metabolic regulation, incretin signaling, and energy balance-associated biochemical pathways